project id: TCGA-STAD; case submitter id: TCGA-B7-A5TN; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.65; rna integrity number: 9.3; age at index: 60; days to birth: -21962; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1952; age at diagnosis: 21962; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 287.0; icd 10 code: C16.1; last known disease status: not reported; morphology: 8144/3; primary diagnosis: Adenocarcinoma, intestinal type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Fundus of stomach; synchronous malignancy: No; tissue or organ of origin: Fundus of stomach; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 50; initial weight: 140.0; sample id: eb871d34-e250-46ff-8005-aed8f889c0ca; sample submitter id: TCGA-B7-A5TN-01A; portion id: f107d9b3-a5ee-4767-9915-c2a781fe48da; portion submitter id: TCGA-B7-A5TN-01A-21; slide id: 95c5df7e-e0dc-4c9d-b141-66e8b3593fa1; slide submitter id: TCGA-B7-A5TN-01A-02-TSB; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 45.0; percent tumor cells: 50.0; percent tumor nuclei: 78.0; section location: TOP;